Revival Healthcare Capital

Name

Revival Healthcare Capital

Legal name

Revival Healthcare Capital, LLC

Website

https://www.rvlhc.com/

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Private Equity / Healthcare Investment

NAICS

Other Financial Vehicles (525990), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

Keywords

• Private equity firm
• MedTech investments
• Build-to-buy partnerships
• Medical device financing
• Healthcare growth capital

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Investment Returns and Capital Gains: Revival Healthcare Capital generates returns through capital appreciation and exit events from their portfolio company investments. As a private capital partnership firm, they deploy capital into MedTech companies through build-to-buy partnerships and growth equity investments, aiming to realize returns upon achievement of milestones or exit events.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Revival Healthcare Capital is a MedTech-focused private equity firm that invests through a Build-to-Buy Partnership Model, deploying private capital alongside leading public healthcare companies to drive external innovation with a predetermined exit path upon achievement of agreed milestones. The firm generally commits at least $50 million per partnership and supplements capital with operational leadership, board governance, and 12 Operating Advisors. It also selectively pursues Special Opportunities investments in commercial-stage MedTech companies where its team has deep market insight.

Product overview

Revival Healthcare Capital is an investment firm specializing in MedTech that operates primarily through a Build-to-Buy Partnership Model, collaborating with leading public healthcare companies to drive external innovation with a minimum $50 million investment commitment per partnership. The firm also selectively pursues Special Opportunities investments in commercial stage MedTech. Its portfolio includes Swan EndoSurgical (gastrointestinal robotics with Olympus), Distalmotion (DEXTER surgical robot for outpatient settings), Metavention, Kardion, and Augmedics. The firm leverages a team of experienced operators and investors along with 12 Operating Advisors to support portfolio companies beyond capital deployment.

Differentiator

Problem solved

Functional benefit

Products and services

• Build-to-Buy Partnership Model A private capital partnership between Revival and leading public healthcare companies that drives external MedTech innovation with a predetermined path to exit upon achievement of agreed-upon milestones; typically involves at least $50 million per partnership.
• Special Opportunities Investment Selective investments in commercial-stage MedTech companies outside of the build-to-buy strategy, in sectors where Revival's team has deep market insight.
• Swan EndoSurgical Gastrointestinal robotics startup launched in partnership with Olympus Corporation, focused on developing robotic systems for minimally invasive gastrointestinal procedures.
• Distalmotion Swiss MedTech company developing the DEXTER soft tissue surgical robot cleared for inguinal hernia repair, cholecystectomy, and benign hysterectomy procedures in outpatient ambulatory surgery center settings.
• Metavention MedTech portfolio company developing metabolic intervention devices for metabolic disease treatment.
• Kardion German MedTech portfolio company developing cardiac-related medical devices.
• Augmedics MedTech portfolio company developing surgical navigation and visualization technology, including the Xvision augmented reality surgical navigation system for spine procedures.

Quantifiable outcome

• Multiple successful exits including Cardiva Medical ($510M acquisition by Haemonetics), Apollo Endosurgery (acquired by Boston Scientific), and others demonstrating investment track record

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core and flagship.

• Medical University of South Carolina (MUSC)coreStrategic or Co-development Partner · 1 April 2026MUSC announced a five-year strategic partnership with Revival Healthcare Capital to accelerate the evaluation, development, and clinical advancement of next-generation medical technologies. Under the agreement, MUSC clinicians provide clinical and procedural insights to inform technology evaluation aligned with Revival's investment strategy, while MUSC leaders may serve as advisors to Revival portfolio companies. The collaboration creates a pathway for Revival to evaluate select MUSC-originated medical device opportunities.
• Olympus CorporationflagshipStrategic or Co-development Partner · 1 July 2025Olympus partnered with Revival Healthcare Capital to launch Swan EndoSurgical, a startup focused on developing robotic gastrointestinal procedures. The initial investment is $65 million, potentially rising to $458 million based on development milestones. Olympus supplies core visualization and endoscopy technology while Revival holds majority control. Olympus retains an option to acquire the startup if pre-set value milestones are achieved.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• PTV Healthcare Capital: Healthcare-focused PE firm and Revival's direct predecessor. Founding partners Rick Anderson and Lauren Buchanan both moved from PTV to Revival, and several team members (Forshey, Rainone, Samford) came from PTV, making it the closest operating and strategic peer.
• Bain Capital Life Sciences: Multi-billion-dollar life sciences PE platform investing across medical devices, biopharma, and diagnostics. Comparable in MedTech focus, fund scale, and partnership with strategics, though broader in mandate than Revival.
• Longitude Capital: Venture and growth equity firm focused exclusively on MedTech, biopharma, and healthcare services. Closely comparable investment stage, healthcare-only focus, and partnership-driven model with strategics.
• Frazier Healthcare Partners: Healthcare-dedicated PE firm investing across medical devices, biopharma, and services. Similar fund size and stage, with comparable growth-equity MedTech strategy.
• Vivo Capital: Healthcare-focused investment firm with MedTech and life sciences growth-equity funds. Comparable in sector specialization, partnership-oriented investing, and backing of commercial-stage MedTech.
• Deerfield Management: Healthcare-dedicated investment manager with PE, venture, and structured capital across devices and life sciences. Comparable MedTech growth-equity activity, though larger and more diversified.
• Ampersand Capital Partners: Specialist healthcare and life sciences PE firm. Comparable in dedicated MedTech mandate and growth-stage investing, with similar fund-size profile.

Emerging players

• Apollo Therapeutics: MedTech and biopharma investor with partnerships across major academic centers. Comparable in partnering with strategics and clinical institutions, though more biopharma-anchored.

Broad incumbents

• KKR Health Care Strategic Growth: Growth-equity platform within KKR focused on healthcare. Overlaps with Revival on MedTech growth deals, but embedded within a much larger generalist PE firm.
• New Enterprise Associates (NEA) - Healthcare: Large venture firm with a significant healthcare practice covering medical devices and diagnostics. Overlaps with Revival on growth-stage MedTech, though broader in stage and sector.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/RVLHC

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Revival Healthcare Capital